N-0877

**N-0877** is an investigational oral fixed-dose antihypertensive combination developed by Eurofarma for **essential arterial hypertension**. It combines an angiotensin receptor blocker with a thiazide diuretic; the individual active ingredients have not been publicly identified in the available trial record. The Phase 3 ATHESA study compares N-0877 with olmesartan + hydrochlorothiazide in adults with stage 2 primary arterial hypertension. ([ctv.veeva.com](https://ctv.veeva.com/study/phase-iii-randomized-double-blind-double-dummy-active-controlled-multicenter-study-on-the-effic))

Brand names

Karb HCTKanarb PlusTuvero

Other names

N 0877N0877N-0877